首页> 外文期刊>Frontiers in Pharmacology >Potential Novel Prediction of TMJ-OA: MiR-140-5p Regulates Inflammation Through Smad/TGF-β Signaling
【24h】

Potential Novel Prediction of TMJ-OA: MiR-140-5p Regulates Inflammation Through Smad/TGF-β Signaling

机译:TMJ-OA的潜在新型预测:miR-140-5p通过SMAD / TGF-β信号调节炎症

获取原文
           

摘要

Temporomandibular joint osteoarthritis (TMJ-OA), mainly exhibit extracellular matrix loss and condylar cartilage degradation, is the most common chronic and degenerative maxillofacial osteoarthritis; however, no efficient therapy for TMJ-OA exists due to the poor understanding of its pathological progression. MicroRNA (miR)-140-5p is a novel non-coding microRNAs (miRNAs) that expressed in osteoarthritis specifically. To investigate the molecular mechanisms of miR-140-5p in TMJ-OA, primary mandibular condylar chondrocytes (MCCs) from C57BL/6N mice were treated with interleukins (IL)-1β or transfected with miR-140-5p mimics or inhibitors, respectively. The expression of matrix metallopeptidase (MMP)-13, miR-140-5p, nuclear factor (NF)-kB, Smad3 and transforming growth factor (TGF)-β3 were examined by western blotting or quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The interaction between the potential binding sequence of miR-140-5p and the 3′-untranslated region (3′UTR) of Smad3 mRNA was testified by dual-luciferase assay. Small Interfering RNA of Smad3 (Si-Smad3) was utilized to further identify the role of Smad3 mediated by miR-140-5p. The data showed MMP13, miR-140-5p and NF-kB increased significantly in response to IL-1β inflammatory response in MCCs, meanwhile, Smad3 and TGF-β3 reduced markedly. Moreover, transfection of miR-140-5p mimics significantly suppressed the expression of Smad3 and TGF-β3 in MCCs, while miR-140-5p inhibitors acted in a converse manner. As the luciferase reporter of Smad3 mRNA observed active interaction with miR-140-5p, Smad3 was identified as a direct target of miR-140-5p. Additionally, the expression of TGF-β3 was regulated upon the activation of Smad3. Together, these data suggested that miR-140-5p may play a role in regulating mandibular condylar cartilage homeostasis and potentially serve as a novel prognostic factor of TMJ-OA-like pathology.
机译:颞下颌关节骨关节炎(TMJ-OA),主要表现出细胞外基质损失和髁突软骨降解,是最常见的慢性和退化的颌面骨质性骨关节炎;然而,由于对其病理进展的理解差,因此没有对TMJ-OA的有效治疗。 microRNA(miR)-140-5p是一种新的非编码微大罗氏(miRNA),其特异性。为了研究TMJ-OA中MIR-140-5P的分子机制,用白细胞介素(IL)-1β处理来自C57BL / 6N小鼠的初级颌骨髁突骨细胞(MCC),或用MIR-140-5P模拟或抑制剂转染。通过蛋白质印迹或定量逆转录聚合酶链反应检查基质金属肽酶(MMP)-13,MIR-140-5P,核因子(NF)-CH,SMAD3和转化生长因子(TGF)-β3的表达(QRT -PCR)。通过双荧光素酶测定法证明了MiR-140-5P的潜在结合序列与Smad3 mRNA的3'-未翻转区域(3'UTR)之间的相互作用。 SMAD3(Si-Smad3)的小干扰RNA用于进一步识别MiR-140-5P介导的Smad3的作用。数据显示MMP13,MIR-140-5P和NF-KB响应于MCCS中的IL-1β炎症反应而显着增加,同时,SMAD3和TGF-β3显着降低。此外,MIR-140-5P模拟的转染显着抑制了MCCs中Smad3和TGF-β3的表达,而MiR-140-5P抑制剂以逆转方式作用。作为Smad3 mRNA的荧光素酶报告者观察到与miR-140-5p的活性相互作用,Smad3被鉴定为miR-140-5p的直接靶标。另外,在Smad3的活化时调节TGF-β3的表达。这些数据表明,MIR-140-5P可能在调节下颌髁突软骨稳态中发挥作用,并且可能用作TMJ-OA样病理的新预后因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号